Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eske Derks

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|May 23, 2020
Cannabis ResearchEske Derks, Karin Verweij, Nathan Gillespie
Schizophrenia Research|March 13, 2012
Social cognition and quality of life in schizophreniaArija Maat, Anne-Kathrin Fett, Eske Derks, et al.
Schizophrenia Research|May 1, 2012
Interpreting treatment trials in schizophrenia patients: lessons learned from EUFESTW Wolfgang Fleischhacker, Eske Derks, Rene S Kahn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 16, 2016
The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trialsTaina Mattila, Maarten Koeter, Tamar Wohlfarth, et al.
Schizophrenia Bulletin|December 22, 2014
Impact of DSM-5 changes on the diagnosis and acute treatment of schizophreniaTaina Mattila, Maarten Koeter, Tamar Wohlfarth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|May 23, 2020
Cannabis ResearchEske Derks, Karin Verweij, Nathan Gillespie
Schizophrenia Research|March 13, 2012
Social cognition and quality of life in schizophreniaArija Maat, Anne-Kathrin Fett, Eske Derks, et al.
Schizophrenia Research|May 1, 2012
Interpreting treatment trials in schizophrenia patients: lessons learned from EUFESTW Wolfgang Fleischhacker, Eske Derks, Rene S Kahn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 16, 2016
The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trialsTaina Mattila, Maarten Koeter, Tamar Wohlfarth, et al.
Schizophrenia Bulletin|December 22, 2014
Impact of DSM-5 changes on the diagnosis and acute treatment of schizophreniaTaina Mattila, Maarten Koeter, Tamar Wohlfarth, et al.
Pageof 1